Oxford Square (OXSQ) Q1 2026 earnings review
A Yield Trap: Core Earnings Collapse While Dilution Accelerates
Oxford Square's fundamentals are deteriorating at an Accelerating pace. The company reported a brutal 26Q1, with Net Asset Value (NAV) plunging 22% sequentially to $1.32. Total investment income Reversing into a sharp decline (-14% YoY) and a spike in realized losses ($30.7M) crushed the bottom line. Most alarmingly, core earnings (Net Investment Income) Decelerated to just $0.05 per share, covering less than half of the $0.105 quarterly distribution. Despite massive NAV destruction, management continues to aggressively issue equity below book value, heavily diluting shareholders to keep the portfolio afloat.
🐂 Bull Case
The weighted average yield of the debt investment portfolio remains Stable at 14.7%, slightly up from 14.5% at the end of 2025. This provides a high-yielding floor for a portion of the interest income.
Cash and equivalents stand at $40.6 million. If credit markets continue to dislocate, management has dry powder to purchase distressed first-lien loans at a discount, as telegraphed in prior strategy updates.
🐻 Bear Case
NII per share ($0.05) covers just 47% of the quarterly distribution ($0.105). Paying out more cash than the portfolio yields directly erodes the principal, guaranteeing further NAV destruction.
Management issued 7.2 million shares via an ATM offering while the stock traded at a steep discount to historic NAV. Expanding the share count by 8% in a single quarter while core earnings drop is highly toxic to existing shareholders.
⚖️ Verdict: 🔴🔴
Bearish. This is a textbook yield trap. With core earnings severely lagging the dividend, an accelerating decline in NAV, and continued below-book equity dilution, the $0.105 quarterly payout appears structurally broken.
Key Themes
NAV Erosion Shifts from Gradual to Severe
Net Asset Value per share has been dropping for quarters, but the pace is Accelerating. NAV fell from $1.69 in 25Q4 to $1.32 in 26Q1—a 22% drop in just three months. Over the past year (since 25Q1), NAV has plummeted 36%. The primary culprit this quarter was an aggressive realization of losses, totaling $30.7 million, wiping out more than three times the total investment income generated.
CLO Equity Yields Collapsing
A specific data point contradicts management's past narrative of 'steady, predictable cash flow' from CLO assets. The weighted average effective yield of the CLO equity investments dropped dramatically from 8.6% in 25Q4 to 7.3% in 26Q1. Consequently, income from securitization vehicles fell 18% YoY to $3.2 million. The portfolio's most critical earnings engine is stalling.
Aggressive, Dilutive Capital Management
The company's At-The-Market (ATM) offering is destroying shareholder value. In 26Q1, they issued 7.2 million shares to raise $12.3 million (net). Selling equity at roughly ~$1.70 per share while the underlying portfolio yields are shrinking simply increases the burden on the remaining assets to cover the massive fixed distribution.
Debt Portfolio Yields Remain Defended
One area remaining Stable is the core debt investment book. The weighted average yield of debt investments at current cost ticked up to 14.7% (vs 14.5% last quarter). Interest income from debt investments contributed $5.1 million, proving to be the sole reliable pillar in the capital structure right now.
Opportunistic Secondary Market Deployment
While 26Q1 saw muted net new deployment (only $15.8M in purchases), management's stated strategy of hunting for less-liquid leveraged loans in the secondary market remains a vital driver. By purchasing assets below par, they aim to capture widened spreads, though the current realized loss profile suggests poor execution on legacy assets.
Product Focus: Long-Dated CLO Equity Structures
Management's primary structural tool/product strategy relies on purchasing 'long-dated' CLO equity tranches from top-tier managers. The thesis is that a longer reinvestment period acts as a structural hedge against market disruptions. While the yields on these vehicles compressed this quarter, they remain the cornerstone of Oxford's strategy to manufacture high double-digit cash distribution yields (currently 13.6%).
Macro Backdrop: U.S. Loan Market Distress Realized
In previous quarters, management warned of rising distress ratios (over 4.3%) and weakness in software/B2B loan pricing. The massive $30.7 million in realized losses this quarter shows that this macro deterioration is no longer just a paper risk—it has crystalized into permanent capital impairment.
Other KPIs
Reversing. After holding steady around $10.2M-$10.4M for four straight quarters, revenue finally cracked, dropping 14% sequentially. This was driven by declines in both debt interest and CLO equity income.
Accelerating loss. This GAAP net income equivalent worsened from -$12.9M in 25Q4 and -$8.1M in 25Q1. It translates to a brutal -$0.29 per share loss for the quarter, largely driven by the clearing of toxic assets via $30.7M in realized losses.
Stable. Down slightly from $5.0M in 25Q4, but up YoY from $4.1M in 25Q1. Notably, interest expense remains a heavy burden following the refinancing of 6.25% notes into 7.75% notes last year, permanently elevating the cost of capital.
Guidance
Stable. The Board declared constant monthly dividends of $0.035 for July, August, and September 2026 ($0.105 for the quarter). While the rate is flat, the likelihood of this being covered by NII is near zero, meaning this distribution is effectively a destructive return of capital.
Key Questions
Dividend Rightsizing
Net Investment Income of $0.05 per share covers less than 50% of the $0.105 quarterly dividend. At what specific NAV threshold or leverage limit will the Board be forced to cut the distribution to align with reality?
Anatomy of the Realized Losses
You recorded a staggering $30.7 million in net realized losses this quarter. What specific sectors, assets, or CLO vintages were liquidated to trigger this, and how much toxic exposure remains on the books?
ATM Offering Logic
The company issued 7.2 million shares this quarter while NAV collapsed to $1.32. How does management justify expanding the share base by 8% at such heavily distressed valuations, which mathematically guarantees dilution for existing shareholders?